GlassScriptPhysician profile
Ann Shue
NPI 1184967796
$1,066.68
in general payments reported to CMS, 2019-2025
7 companies · $77.55 in 2025
The $77.55 reported for 2025 was less than what a typical Pediatric Ophthalmology and Strabismus Specialist provider received nationally (typical 2025 total: $118).
See the full distribution for Pediatric Ophthalmology and Strabismus Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $109 · 2021: $24.89 · 2022: $214 · 2023: $246 · 2024: $396 · 2025: $77.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $383.80 | 2022-2025 | Hydrus Microstent, Precision 1 |
| Sight Sciences, INC. | $305.56 | 2020-2024 | Omni Surgical System |
| Glaukos Corporation | $92.88 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Abbvie INC. | $82.54 | 2023 | Xen Glaucoma Treatment System |
| Apellis Pharmaceuticals, INC. | $73.86 | 2023 | Syfovre |
| Johnson & Johnson Surgical Vision, INC. | $67.94 | 2022-2024 | Tecnis Iol, Tecnis Simplicity |
| Allergan, INC. | $60.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Shue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.